United States Department of Health and Human Services obtains United States patent.

From: BIOTECH Patent News | Date: August 1, 2006 | Copyright information

The United States Department of Health and Human Services (Washington, DC) has patented a vaccine for inducing an immune response in mammal to a specific antigen, where the vaccine comprises a unit dose of a binary toxin protective antigen and the antigen, which is bound to a binary toxin protective antigen binding protein. In one embodiment the vaccine is c...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Comparative evaluation of protective antigen produced from Bacillus anthracis & Escherichia coli
Indian Journal of Medical Research ; Background & objective: Anthrax has been reported from almost every country and India is endemic for this disease. There is considerable under reporting of the disease because of lack of microbiological facilities and diagnostic reagents. In India only conventional methods which have
A New Approach to Anthrax : As Published in the Proceedings of the National Academy of Sciences
U.S. Newswire ; OKLAHOMA CITY, Okla., Dec. 2 /U.S. Newswire/ -- Researchers from Harvard University and the University of Oklahoma are being recognized for their unique approach to anthrax vaccination development. An article detailing their work is featured in a recent issue of the Proceedings of the National
ANTHRAX ANTIDOTE PROMISING, STUDY FINDS.(NEWS)
The Cincinnati Post (Cincinnati, OH) ; Byline: Associated Press SAN FRANCISCO -- An experimental anthrax antidote has protected rats injected with the bacterium's deadly toxin, researchers found. University of Texas researchers say they've genetically engineered a mouse protein that offers an anthrax toxin a more attractive docking site
Vical gets grant to further develop an Anthrax vaccine. (Biotech).(3-year $5.7 mn government grant)(Brief Article)
San Diego Business Journal ; Anthrax vaccine: Vical Inc., a San Diego-based vaccine maker, recently said it was awarded a three-year $5.7 million government grant to further develop its anthrax vaccine. Vical said the new funding won't change its net loss forecast for 2003. The biotech will use this second grant from the U.S.
Researchers developing anthrax antidote; Promising: The research targets the late stage of the deadly disease
Telegraph - Herald (Dubuque) ; SAN FRANCISCO (AP) - An experimental anthrax antidote has protected rats injected with the bacterium's deadly toxin, researchers found. University of Texas researchers say they've genetically engineered a mouse protein that offers an anthrax toxin a more attractive docking site than its usual
ANTHRAX VACCINE MOVES INTO CLINICAL TRIALS
Regulatory Intelligence Data ; FORT DETRICK, Md., July 9, 2003 - The next-generation anthrax vaccine, based on a decade of work at the U.S. Army Medical Research Institute of Infectious Diseases, is now moving into not one, but four clinical trials. The group at the institute did the legwork for the current vaccine candidates by
New vaccine could strike double blow to anthrax
The Milwaukee Journal Sentinel ; New vaccine could strike double blow to anthrax All the mice survive in test targeting both germ and toxin By MARILYNN MARCHIONE mmarchione@journalsentinel.com, Journal Sentinel Tuesday, September 2, 2003 Scientists have developed a new type of anthrax vaccine that could be the first to protect
Cutaneous anthrax, Belgian traveler.(LETTERS)(Letter to the editor)
Emerging Infectious Diseases ; To the Editor: Anthrax is a rare zoonotic disease among travelers. The clinical spectrum includes cutaneous lesions, respiratory anthrax, pharyngeal inflammation, gastrointestinal infection, septicemia, and meningitis. Interest in anthrax increased after the bioterrorist attacks in the United
New Vaccine Could Strike Double Blow to Anthrax.
The Milwaukee Journal Sentinel (Milwaukee, Wisconsin) (via Knight-Ridder/Tribune Business News) ; ... Wisconsin-Madison; New York Times The Toxic Cycle To see more of the Milwaukee Journal Sentinel, or to subscribe to the newspaper, go to http://www.jsonline.com. (c) 2003, Milwaukee Journal Sentinel. Distributed by Knight Ridder/Tribune Business News.
The Seminal Literature of Anthrax Research
Critical Reviews in Microbiology ; ... Meyer, R.F., Bray, D., Nichelson, D., and Miller, J.M. 2003. Detecting biothreat agents: the Laboratory Response Network. ASM News 69, 433^137. Mourez, M., Lacy, D.B., Cunningham, K., Legmann, R., Sellman, B.R., Mogridge, J., and Collier, RJ. 2002. 2001: A ...